Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank R Ernst

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Clinical Drug Investigation|November 1, 2016
The Economic Impact of Levothyroxine Dose Adjustments: the CONTROL HE StudyFrank R Ernst, Peri Barr, Riad Elmor, et al.
Pragmatic and Observational Research|July 25, 2024
Advanced Multi-Layer Watertight Closure versus Conventional Closure in Total Hip and Knee Replacement SurgeryJana L Flener, Brian Po-Han Chen, Frank R Ernst, et al.
Surgical Infections|March 17, 2016
Evaluation of Tigecycline Efficacy and Post-Discharge Outcomes in a Clinical Practice Population with Complicated Intra-Abdominal Infection: A Propensity Score-Matched AnalysisJoseph Solomkin, C Daniel Mullins, Alvaro Quintana, et al.
Clinical Therapeutics|November 22, 2016
Value of Propensity Score Matching for Equalizing Comparator Groups in Observational Database Studies: A Case Study in Anti-infectivesC Daniel Mullins, Frank R Ernst, Michelle R Krukas, et al.
Current Medical Research and Opinion|July 19, 2014
Real-world observations with prasugrel compared to clopidogrel in acute coronary syndrome patients treated with percutaneous coronary intervention in the United StatesJay P Bae, Douglas E Faries, Frank R Ernst, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 9, 2016
Comparative resource utilization and costs for patients with acute coronary syndrome managed with percutaneous coronary intervention and treated with clopidogrel or prasugrelJay P Bae, Douglas E Faries, Frank R Ernst, et al.
Journal of Medical Economics|March 5, 2013
A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropeniaBrian Dulisse, Xiaoyan Li, Julie A Gayle, et al.
BMC Nephrology|May 15, 2025
PLASMIC score to aid diagnosis of aHUS: an analysis of C5 inhibitor clinical trials and the PINC AI™ healthcare databaseMiguel G Uriol-Rivera, Frank R Ernst, John N Booth, et al.
Journal of the American Geriatrics Society|July 23, 2016
Treatment for Multiple Acute Cardiopulmonary Conditions in Older Adults Hospitalized with Pneumonia, Chronic Obstructive Pulmonary Disease, or Heart FailureKumar Dharmarajan, Kelly M Strait, Mary E Tinetti, et al.
Journal of Medical Economics|December 13, 2025
Comparison of work productivity losses in the United States among employees with COVID-19 at high-risk of severe disease who were untreated or treated with nirmatrelvir/ritonavirMaria M Fernandez, Brenna L Brady, Kristin A Evans, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Clinical Drug Investigation|November 1, 2016
The Economic Impact of Levothyroxine Dose Adjustments: the CONTROL HE StudyFrank R Ernst, Peri Barr, Riad Elmor, et al.
Pragmatic and Observational Research|July 25, 2024
Advanced Multi-Layer Watertight Closure versus Conventional Closure in Total Hip and Knee Replacement SurgeryJana L Flener, Brian Po-Han Chen, Frank R Ernst, et al.
Surgical Infections|March 17, 2016
Evaluation of Tigecycline Efficacy and Post-Discharge Outcomes in a Clinical Practice Population with Complicated Intra-Abdominal Infection: A Propensity Score-Matched AnalysisJoseph Solomkin, C Daniel Mullins, Alvaro Quintana, et al.
Clinical Therapeutics|November 22, 2016
Value of Propensity Score Matching for Equalizing Comparator Groups in Observational Database Studies: A Case Study in Anti-infectivesC Daniel Mullins, Frank R Ernst, Michelle R Krukas, et al.
Current Medical Research and Opinion|July 19, 2014
Real-world observations with prasugrel compared to clopidogrel in acute coronary syndrome patients treated with percutaneous coronary intervention in the United StatesJay P Bae, Douglas E Faries, Frank R Ernst, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 9, 2016
Comparative resource utilization and costs for patients with acute coronary syndrome managed with percutaneous coronary intervention and treated with clopidogrel or prasugrelJay P Bae, Douglas E Faries, Frank R Ernst, et al.
Journal of Medical Economics|March 5, 2013
A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropeniaBrian Dulisse, Xiaoyan Li, Julie A Gayle, et al.
BMC Nephrology|May 15, 2025
PLASMIC score to aid diagnosis of aHUS: an analysis of C5 inhibitor clinical trials and the PINC AI™ healthcare databaseMiguel G Uriol-Rivera, Frank R Ernst, John N Booth, et al.
Journal of the American Geriatrics Society|July 23, 2016
Treatment for Multiple Acute Cardiopulmonary Conditions in Older Adults Hospitalized with Pneumonia, Chronic Obstructive Pulmonary Disease, or Heart FailureKumar Dharmarajan, Kelly M Strait, Mary E Tinetti, et al.
Journal of Medical Economics|December 13, 2025
Comparison of work productivity losses in the United States among employees with COVID-19 at high-risk of severe disease who were untreated or treated with nirmatrelvir/ritonavirMaria M Fernandez, Brenna L Brady, Kristin A Evans, et al.
Pageof 5